e-learning
resources
London 2016
Sunday, 04.09.2016
What's new in biomarker analysis?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Signalling through the receptor for advanced glycation end products (RAGE) is increased in acute asthma and correlates with symptom severity
Asger Bjerregaard (Hillerod, Denmark), Asger Bjerregaard, Celeste Porsbjerg, Lucy Barrett, Ingrid Laing, Siew-Kim Khoo, Markus Fally, Peter Le Souëf, Vibeke Backer, Philip Thompson, Svetlana Baltic
Source:
International Congress 2016 – What's new in biomarker analysis?
Session:
What's new in biomarker analysis?
Session type:
Thematic Poster
Number:
904
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Asger Bjerregaard (Hillerod, Denmark), Asger Bjerregaard, Celeste Porsbjerg, Lucy Barrett, Ingrid Laing, Siew-Kim Khoo, Markus Fally, Peter Le Souëf, Vibeke Backer, Philip Thompson, Svetlana Baltic. Signalling through the receptor for advanced glycation end products (RAGE) is increased in acute asthma and correlates with symptom severity. Eur Respir J 2016; 48: Suppl. 60, 904
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Receptor of advanced glycation end products in childhood asthma exacerbation
Source: International Congress 2016 – Paediatric asthma: from amniotic fluid to dirty streets
Year: 2016
Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015
Increased expression of receptor for advanced glycation end products in COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Receptor for advanced glycation end products (RAGE) is involved in cigarette smoke induced inflammation and emphysema
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Soluble RAGE is deficient in neutrophilic asthma and COPD
Source: Eur Respir J 2012; 39: 721-729
Year: 2012
TLR4 and NOD1 increase in stable COPD of increasing severity. Relationship with tissutal bacterial load
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
Coagulation activity increases with disease severity in patients with asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Reduced soluble receptor for advanced glycation end-products in COPD
Source: Eur Respir J 2011; 37: 516-522
Year: 2011
IL-25 receptor expression on basophil membrane is related to phenotype and severity of asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Loss of receptor for advanced glycation end products (RAGE) in idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007
Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021
Alterations in gene expression of RAGE and its sheddases in blood of COPD patients do not relate to decreased plasma (e)sRAGE levels
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Modulation of cytotoxic effects of histones by osteopontin
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Increased laminin deposition and expression of TGF-beta in bronchial biopsies of children with chronic obstructive respiratory diseases
Source: Annual Congress 2013 –Paediatric bronchology
Year: 2013
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Various biomarkers of oxidative stress in patients with uncontrolled asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept